We have isolated the gene encoding mouse placental lactogen-I and characterized the promoter region of this gene by transient and stable transfection. Promoter sequences extending 274 basepairs (bp) up-stream from the start site of transcription contain all of the elements necessary for maximal expression upon transient transfection into the rat choriocarcinoma Rcho-1 cell line; these Rcho-1 cultures contain both proliferative trophoblast stem cells and terminally differentiated trophoblast giant cells. In stably transfected cell lines, expression from this promoter increases as the percentage of differentiated cells in the culture increases.
In contrast to these results in trophoblast cells, the 274-bp promoter as well as a promoter region extending 2700 bp up-stream of the transcriptional start site are unable to drive transcription in a variety of other cell types. Mutational and protein binding analyses indicate that two AP-1 sites are required for maximal expression in Rcho-1 cells, and that the composition of the AP-1 transcription factor may vary as differentiation in the cell culture increases.
In addition to these two AP-1 sites, at least one other element appears to be critical for promoter activity in trophoblast cells. (Molecular Endocrinology 7: 181-188, 1993) 
INTRODUCTION
The development of the extraembryonic cell lineages in mammals includes the differentiation of multiple placental trophoblast cell types. One of the functions of these trophoblast cells is the synthesis and secretion of hormones that regulate both maternal and fetal physiology. Among these secreted proteins in rodents, ruminants, and primates are members of the PRL/GH family. In osee-8809/93/0181-0188$03.00/0 Molecular Endocrinology CopyrIght 0 1993 by The Endocrine Soxty rodents, these hormones are found to be synthesized in either the trophoblast giant cells or the spongiotrophoblasts (1); two of these hormones, placental lactogen-I (PL-I) (2, 3) and PL-II (2-6). are synthesized exclusively in the trophoblast giant cells and functionally replace PRL during pregnancy (7).
Both PL-I (8) and PL-II (9) bind to the PRL receptor with high affinity, and both hormones have PRL-like activities (7). Although these biological activities may be as numerous and varied as those induced by PRL (lo), some of the primary activities of PL-I and PL-II during gestation are the maintenance of the corpus luteum, the regulation of maternal carbohydrate metabolism in the liver, and the development of the mammary glands for postpartum lactation (7). These two placental hormones also enter the fetal circulation, where they may participate directly in the growth and development of the fetus (7). Synthesis of PL-I is first detected soon after implantation (1 I), but significant quantities of this hormone are not present in the circulation until midgestation (12). On gestational day 10 in the mouse, PL-I levels peak at approximately 8 pg/ml in the maternal serum, and then rapidly decline (12). In contrast, PL-II synthesis does not commence until midpregnancy, and the concentration of this hormone achieved by gestational day 12 is maintained or gradually increases until term to a level of 0.5-l pg/ml in maternal serum (7).
The transcriptional factors and genetic elements regulating the specific expression of these hormone genes in placental trophoblast giant cells and those governing the switch from PL-I to PL-II synthesis are unknown. We have characterized a region of the mPL-II gene sufficient for directing transcription specifically in the trophoblast giant cells of transgenic mice, but this region is large (2.7 kilobases), and this approach is limited in dissecting such a large regulatory region (13). One of the major limitations in defining these regulatory components has been the lack of a suitable continuous cell culture system for expression of rodent PL-I and PL-II. The recent development of the Rcho-1 cell line (14) provides a potential cell system for investigating PL gene expression and studying trophoblast differentiation. Rcho-1 cells, derived from a transplantable rat choriocarcinoma (15). differentiate in culture into giant cells that produce both PL-I and PL-II. Conditions in which these cells display a decrease in PL-I expression and, concurrently, an increase in PL-II expression (as seen in giant trophoblast cells in vivo) have not been found; these cell cultures may, therefore, prove useful in identifying extracellular regulators or missing intracellular components of the switch from PL-I to PL-II synthesis. In contrast, the synthesis of both of these hormones indicates that these cells do contain the regulatory factors necessary for trophoblast-specific PL gene expression. Thus, we have now used this cell system to define a region of the mouse PL-I (mPL-I) gene promoter that directs transcription specifically in trophoblast cells.
RESULTS

Isolation of the mPL-I Gene
The mPL-I gene was isolated from a mouse genomic DNA library by screening with the mPL-I cDNA (16). Genomic fragments containing the first exon and upstream sequences were subcloned into a plasmid vector under the assumption that the regulatory elements essential for trophoblast-specific expression would be located up-stream of the transcription start site. The sequence of this up-stream region and exon I is shown in Fig. 1 ; the start site of transcription was mapped by primer extension to a position 63 basepairs (bp) upstream of the translation initiating ATG in exon 1 (Fig.  2) . To determine whether sequences up-stream of this transcriptional start site can direct trophoblast-specific expression, an initial set of constructs was prepared linking the mPL-I up-stream sequences from positions -2700 to +2, -274 to t-2, or -64 to +2 to the bacterial chloramphenicol acetyltransferase (CAT) gene. These constructs, designated 5'-2700CAT, 5'-274CAT, and 5'-64CAT, respectively, all contain the mPL-I gene TATA box at position -30.
Transient Transfection of mPL-I Promoter Constructs
These three promoter constructs were transiently transfected into Rcho-1 cells, and both 5'-2700CAT and 5'-274CAT were found to be active in this cell line (Fig. 3) . Moreover, the amount of CAT enzymatic activity detected in Rcho-1 cells transfected with 5'-274CAT was consistently greater than that obtained by transfection of 5'-2700CAT, which may reflect the presence of negatively acting regulatory sequences up-stream of position -274. In contrast to the 5'-274CAT and 5'-2700CAT promoter constructs, 5'-64CAT yielded undetectable CAT activity in transfected Rcho-1 cells. Thus, one or more of the elements required for directing transcription in Rcho-1 cells from the mPL-I gene promoter are located between positions -64 and -274. To determine whether the activity of the -2700 and -274 promoter regions was specific for the Rcho-1 cells, these DNA constructs were also introduced into Chinese hamster ovary (CHO) cells (Fig. 3) monkey Cos-7 cells, and mouse L-cells. In each of these cell lines, no significant transcription could be detected from any of these three promoter constructs. In comparison, the Rous sarcoma virus (RSV) promoter (in RSV-CAT) was highly active in both CHO and Rcho-1 cells (Fig.  3) .
Stable Transfection of mPL-I Promoter Constructs
Clonal Rcho-1 cell cultures contain a mixture of proliferative small cells and terminally differentiated giant cells; under differentiation conditions, the percentage of giant cells in the population and the expression of PL-I increase, indicating that the small cells are probably giant cell precursors (14). To verify that the two active promoter constructs, 5'-2700CAT and 5'-274CAT, were expressed in a manner similar to the endogenous mPL-I gene, these constructs were stably introduced into Rcho-1 cells by cotransfection with the plasmid pSV2-neo and selection for G418 resistance. Several independent, stably transfected cell lines were established in this manner. Two of these cell lines generated with 5'-274CAT
(clones 16 and 17) and two transfected with 5'-2700CAT
(clones 3 and 19) were then examined for CAT activity within 2 days of plating, when differentiation is minimal, and 1 week after shifting cells from growth medium to differentiation medium, when the percentage of giant cells and expression of endogenous PL genes are high. Although the level of CAT activity varies among the independent clones (most likely due to positional and copy number variations of the transfected DNA), CAT expression from the 5'-2700 promoter and the 5'-274 promoter increased upon cell differentiation in each stably transfected cell line (Fig.  4) . Consistent with the transient transfection results, the 5'-64CAT construct was also inactive in stably transfected, differentiated cell cultures (data not shown).
Functional
Role of AP-1 Elements within the mPL-I Promoter Inspection of the mPL-I promoter sequence between positions -64 and -274 reveals two potential AP-1 elements, the target of jun-jun homodimers and jun-fos heterodimers (17). The proximal AP-1 site (TGACTCA) is located between residues -80 and -74, and the upstream site (TGAGTAA) lies between positions -246 and -240. To test the importance of these two sequences for transcriptional activity of the mPL-I gene The nucleotide sequence of the mPL-I promoter from the EcoRl site at -274 through exon 1 is shown. The start site of transcription is position 1. The two AP-1 sites are boxed, the TATA box is underlined, and a conserved heptad repeat is marked by the three arrows. The coding region begins at position 63, and exon 1 terminates within codon 11 (GCA = alanine).
promoter in trophoblast giant cells, mutations at each of these AP-1 sites were generated. For the downstream AP-1 site, the sequence TGACTCA was converted to atACTCA in the construct designated SDM -8O/-79;
for the up-stream AP-1 site, the sequence TGAGTAAT was altered to a Bglll restriction endonuclease site (gagaTctc) to generate SDM -246/-239. Both of these mutations were made within the promoter extending to position -274. The resultant modified promoters were transiently transfected into Rcho-1 cells. Site-directed mutation of either of these AP-1 sites reduced, but did not eliminate, transcription from the mPL-I promoter (Fig. 5) .
To determine if the up-stream site is a target for factors in Rcho-1 cells, in particular AP-1, a double stranded oligonucleotide spanning this sequence was incubated with purified c-jun protein or Rcho-1 cell extracts and subjected to electrophoresis.
Purified cjun protein did bind this sequence, as did factors present in the Rcho-1 extracts. Furthermore, a consensus AP-1 oligonucleotide (Promega, Madison, WI) was able to compete for binding to this up-stream sequence (Fig.  6 ). This consensus oligonucleotide, which has the same core sequence as the down-stream mPL-I AP-1 site, also bound AP-1 in Rcho-1 cell extracts when used as the radiolabeled probe (data not shown).
Comparison of the size of the DNA-protein complex that forms with purified c-jun protein vs. Rcho-1 cell extracts suggested that the complex from Rcho-1 cell extracts is not simply a homodimer of c-jun. To identify components of this complex, binding reactions were supplemented with antiserum against c-jun, jun-B, jun-D, or c-fos. The c-fos antiserum completely blocked complex formation using extracts from either undiffer- cating that most or all of the bound AP-1 detected in this assay is in the form of jun-fos heterodimers rather than jun-jun homodimers. Addition of c-jut? antiserum resulted in a supershift of a subset of the protein-DNA complexes formed with undifferentiated cell extracts, suggesting that c-jut? is present in some, but perhaps not all, of the bound AP-1; with differentiated cell extracts, the c-jun antiserum had no observable effect. The jun-B antiserum caused a partial reduction in the amount of complex detected with undifferentiated Rcho-1 cell extracts, but nearly complete inhibition of complex formation with differentiated cell extracts. In contrast, anti-jun-D had no observable effect, and unlike the other two forms of jun, jun-D mRNA was not detected in Rcho-1 cells in hybridizations with the corresponding mouse cDNA clone (data not shown).
Additional Elements within the mPL-I Promoter
Comparison of the promoter sequence to a transcriptional element database (Genetics Computer Group, Madison, WI) did not reveal the presence of any previously characterized elements in addition to the AP-1 sites and the TATA box. We, therefore, sought to identify other regions of the -274 promoter that may be involved in trophoblast-specific transcriptional regulation. Mutation of the -274 promoter by deletion to -242 (partway through the up-stream AP-1 site) results in the construct 5'-242CAT with partial activity, while further deletion to -188 (5'-188CAT) renders the promoter inactive and equivalent to the 5'-64CAT construct (Fig. 8) . Thus, an essential element for Rcho-1 cell expression appears to be located within a 54-bp region between the up-stream AP-1 site and position -188. Inspection of this region reveals the presence of a duplicated heptad sequence, TCCAGAT, at positions -231 to -225 and -192 to -186; halfway between these repeats, from -208 to -214, is a heptad se- quence in the opposite orientation that differs by 1 bp (TCCAaAT; Fig. 1 ).
DISCUSSION
The current studies demonstrate that the rat choriocarcinema cell line Rcho-1 provides a valuable system for studying trophoblast cell-specific gene expression. The mPL-I gene promoter has strong transcriptional activity in this cell background, but no detectable activity in any of the nontrophoblast cell lines that were examined. Sequences up-stream of the mPL-I gene transcription start site extending to -274 and -2700 are both effective at driving expression of a linked reporter gene in Rcho-1 cells, although the -274 promoter apparently has greater activity. Thus, the -274 to 2 region appears at -240 to -246, approximately the same position as the AP-1 site (at -225 to -231) in the related proliferin gene promoter (19); both the mPL-I and proliferin genes (5) are active specifically in trophoblast giant cells, with maximal levels of both of these mRNAs present on gestational day 10 (16, 20) . The locations of these AP-1 elements are also similar to the position of a CAMP response element (at -248 to -255) in the mPL-II gene promoter (13). Since AP-1 and factors that act through a CAMP response element have overlapping activities (21) AP-1 and related factors may be critical for transcription of each of the placental members of the PRLrelated gene family in vivo.
Since AP-1 is a ubiquitous transcription factor complex, the lack of mPL-I promoter activity in nontrophoblast cells indicates that two functional AP-1 elements in conjunction with a TATA box are not necessarily sufficient for promoter activity. One possible explanation for this finding is that other sequences in the -1 to -274 region function as repressors, perhaps blocking AP-1 activity. This is seen in the proliferin gene promoter, in which sequences adjacent to the AP-1 site can affect AP-1 function and promoter activity (19, 22) (Mordacq, J. C., M. Athaide, and D. I. H. Linzer, unpublished observations). Another possibility is that the mPL-I gene AP-1 sites interact preferentially with a subset of the many AP-1 factor forms, and that these interactive forms are present at higher levels in Rcho-1 cells than in other cell types. The AP-1 forms in undifferentiated Rcho-1 cell extracts that interact with the mPL-I upstream site appear to be primarily c-fos/c-jun and c-fos/ jun-B heterodimers, while in differentiated cells, the form of AP-1 bound to this site is mostly the c-fos/jun-B heterodimer; this change in the bound form of AP-1 upon differentiation may be important for the activity of this promoter in trophoblast giant cells.
Although the AP-1 sites are required for maximal promoter activity, it seems unlikely that these elements, which are recognized by factors present in many cell types, are sufficient for dictating trophoblast-specific expression of the mPL-I promoter. At least one other element does appear to be required for transcription from the mPL-I gene promoter, lying within a 54-bp region between the up-stream AP-1 site and position -188, as defined by 5'-deletion mutagenesis of the promoter.
Unlike the in viva situation, differentiated Rcho-1 cells continue to synthesize PL-I even after extended culture times (14). Thus, this system has not yet revealed what signals lead to the deactivation of PL-I gene expression and the coincident switch from PL-I to PL-II synthesis. The isolation of stably transfected cell lines that activate the mPL-I gene promoter upon cell differentiation may prove useful in analyzing the effects of various extracellular factors on the transcriptional activity of the mPL-I gene promoter, potentially enabling factors to be identified that are involved in the deactivation of the mPL-I gene during the latter half of gestation. The switch in expression of the PL genes also represents a useful molecular marker for trophoblast cell differentiation. The current classification of trophoblast cells largely by morphology (e.g. giant cells) underscores the need to define more subtle molecular differences between these cells that lead to distinct trophoblast cell functions in pregnancy. Analysis of the expression of the PL genes may lead to characterization of the genetic elements and transcription regulatory factors that are involved in a broader program of trophoblast gene expression and cellular differentiation. Cultures were transfected in 6-cm dishes and harvested 2 days later. All other cell types were transfected using diethylaminoethyldextran (24). For quantitations of promoter activity, 2 pg of the plasmid PA~RSV.,~,,LUC (25) were included in cotransfections as an internal control. However, transfections quantifying mPL-I promoter activity were also conducted in parallel without this internal control due to observed competition between the RSV and mPL-I promoters.
MATERIALS AND METHODS
This internal control was also used to ensure that transfections with mPL-I promoter constructs lacking activity were successful. CAT assays were performed as previously described (26) using 60 pg cell extract; luciferase assays were conducted with 30 pg cell extract, as previously described (27) 
